World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
25712
World Ranking
16076
National Ranking
8091

Overview

Amil M. Shah is affiliated with Harvard University in the United States and has made significant contributions primarily in the field of Medicine.

Their research predominantly focuses on several subfields including Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Molecular Biology, and Epidemiology.

Shah's work covers key topics related to cardiovascular health and disease management, especially:

  • Cardiovascular Function and Risk Factors
  • Heart Failure Treatment and Management
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Health and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Disease and Adiposity
  • Cardiac Valve Diseases and Treatments

The scientist's frequent publication venues reflect their focus on cardiovascular medicine, with numerous contributions to:

  • Circulation
  • Journal of the American College of Cardiology
  • UNC Libraries
  • Journal of the American Heart Association
  • European Heart Journal

Among recent papers, Shah's work includes studies such as:

  • "Association of Clonal Hematopoiesis With Incident Heart Failure," 2021, Journal of the American College of Cardiology
  • "Association of Isolated Diastolic Hypertension as Defined by the 2017 ACC/AHA Blood Pressure Guideline With Incident Cardiovascular Outcomes," 2020, JAMA
  • "Lung function and cardiovascular disease: A link," 2020, Trends in Cardiovascular Medicine
  • "Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community," 2020, JACC Heart Failure
  • "Left atrial function in heart failure with preserved ejection fraction: a systematic review and meta-analysis," 2020, European Journal of Heart Failure

Shah has collaborated frequently with several researchers in the cardiovascular field, including:

  • Scott D. Solomon
  • Brian Claggett
  • Kunihiro Matsushita
  • Christie M. Ballantyne
  • Hicham Skali

Best Publications

  • The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: A phase 2 double-blind randomised controlled trial

    Scott D. Solomon;Michael R. Zile;Burkert Pieske;Adriaan A Voors

  • Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Merrill D. Benson;Márcia Waddington-Cruz;John L. Berk;Michael Polydefkis

  • Vitamin D levels and early mortality among incident hemodialysis patients.

    M. Wolf;A. Shah;O. Gutierrez;E. Ankers

  • Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction

    Elisabeth Kraigher-Krainer;Amil M. Shah;Deepak K. Gupta;Angela Santos

  • Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis.

    Sara B Seidelmann;Brian Claggett;Susan Cheng;Mir Henglin

  • Heart Failure With Preserved Ejection Fraction In Perspective.

    Marc A. Pfeffer;Amil M. Shah;Barry A. Borlaug

  • Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease: The PRIMO Randomized Controlled Trial

    Ravi Thadhani;Evan Appelbaum;Yili Pritchett;Yuchiao Chang

  • Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction.

    James L. Januzzi;Margaret F. Prescott;Javed Butler;G. Michael Felker

  • Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction Baseline Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial

    Amil M. Shah;Sanjiv J. Shah;Inder S. Anand;Nancy K. Sweitzer

  • Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction

    Viviany R Taqueti;Scott D Solomon;Amil M Shah;Akshay S Desai

  • Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

    Scott D. Solomon;David Adams;Arnt Kristen;Martha Grogan

  • Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.

    Amil M. Shah;Brian Claggett;Nancy K. Sweitzer;Sanjiv J. Shah

  • Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy

    Scott D. Solomon;Elyse Foster;Mikhail Bourgoun;Amil Shah

  • Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study.

    Tor Biering-Sørensen;Sofie Reumert Biering-Sørensen;Flemming Javier Olsen;Morten Sengeløv

  • Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF.

    John J.V. McMurray;Alice M. Jackson;Carolyn S.P. Lam;Carolyn S.P. Lam;Carolyn S.P. Lam;Margaret M. Redfield

  • Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial

    Tomasz Siminiak;Justina C. Wu;Michael Haude;Uta C. Hoppe

  • Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction

    Angela B S Santos;Angela B S Santos;Gabriela Querejeta Roca;Brian Claggett;Nancy K. Sweitzer

  • Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

    Akshay S. Desai;Scott D. Solomon;Amil M. Shah;Brian L. Claggett

  • Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction

    Amil M. Shah;Brian Claggett;Nancy K. Sweitzer;Sanjiv J. Shah

  • Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease

    Ravi Thadhani;Evan Appelbaum;Yili Pritchett;Julia Wenger

Frequent Co-Authors

Scott D. Solomon
Scott D. Solomon Brigham and Women's Hospital
Brian Claggett
Brian Claggett Brigham and Women's Hospital
Susan Cheng
Susan Cheng Cedars-Sinai Medical Center
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Kunihiro Matsushita
Kunihiro Matsushita Johns Hopkins University
Dalane W. Kitzman
Dalane W. Kitzman Wake Forest University
Elizabeth Selvin
Elizabeth Selvin Johns Hopkins University
Marc A. Pfeffer
Marc A. Pfeffer Harvard Medical School
Josef Coresh
Josef Coresh New York University
Thomas H. Mosley
Thomas H. Mosley University of Mississippi Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens the door to a wide range of related degrees and specializations. Many students consider online programs that combine flexibility with affordability, allowing them to advance their education without pausing their careers.

For those interested in healthcare leadership, an affordable mha online can prepare you for executive roles in hospitals, clinics, and other medical organizations. Alternatively, nurses looking to advance can benefit from enrolling in a cheapest dnp program, enabling them to reach the highest levels of clinical practice.

Pharmacy professionals may be interested in a 3-year online pharmd to deepen their expertise with the flexibility of remote study. If your passion lies in managing and securing medical data, pursuing a him bachelor's degree online can lead to rewarding positions at the intersection of healthcare and technology.

Each of these pathways offers unique opportunities, so prospective students should consider their career goals, budget, and preferred learning format when choosing the best program.

Best Scientists Citing Amil M. Shah

Trending Scientists

Recently Published Articles